{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:04:35Z","timestamp":1785182675221,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K17953"],"award-info":[{"award-number":["20K17953"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K09451"],"award-info":[{"award-number":["19K09451"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The presence of disease-specific antigens and autoantibodies in the sera of patients with atherosclerosis-related diseases has been widely reported and is considered to result from inflammation of the arterial wall and the involvement of immune factors. The aim of this study was to identify a novel antibody in patients with ischemic stroke by serological identification of antigens using recombinant cDNA expression cloning from patients who had a transient ischemic attack (TIA). We identified the serpin peptidase inhibitor, clade E member 1 (SERPINE1), as a candidate antigen. The serum anti-SERPINE1 antibody levels quantified using amplified luminescent proximity homogeneous assay-linked immunosorbent assay were significantly higher in patients with ischemic stroke, including those with acute cerebral infarction (aCI), TIA, and chronic cerebral infarction, than in healthy donors. The antibody levels were strongly associated with old age, female sex, and presence of hypertension, diabetes mellitus, and cardiovascular disease. Age and intima-media thickness of the carotid artery were positively correlated with antibody levels, which suggests that SERPINE1 may reflect the progression of atherosclerosis. In a multivariate analysis, SERPINE1 antibody level was an independent predictor of aCI. Thus, the serum levels of anti-SERPINE1 antibody could potentially serve as a biomarker of atherothrombotic infarction.<\/jats:p>","DOI":"10.1038\/s41598-021-01176-8","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T11:06:21Z","timestamp":1636110381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction"],"prefix":"10.1038","volume":"11","author":[{"given":"Masaaki","family":"Kubota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Matsutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Shi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Mine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaki","family":"Hiwasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Iwadate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"1176_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","volume":"42","author":"LB Goldstein","year":"2011","unstructured":"Goldstein, L. B. et al. Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 42, 517\u2013584. https:\/\/doi.org\/10.1161\/STR.0b013e3181fcb238 (2011).","journal-title":"Stroke"},{"key":"1176_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0167-5699(95)80067-0","volume":"16","author":"G Wick","year":"1995","unstructured":"Wick, G., Schett, G., Amberger, A., Kleindienst, R. & Xu, Q. Is atherosclerosis an immunologically mediated disease?. Immunol. Today 16, 27\u201333. https:\/\/doi.org\/10.1016\/0167-5699(95)80067-0 (1995).","journal-title":"Immunol. Today"},{"key":"1176_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1741-7015-12-47","volume":"12","author":"E Matsuura","year":"2014","unstructured":"Matsuura, E. et al. Is atherosclerosis an autoimmune disease?. BMC Med. 12, 47. https:\/\/doi.org\/10.1186\/1741-7015-12-47 (2014).","journal-title":"BMC Med."},{"key":"1176_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1161\/01.ATV.0000149142.42590.a2","volume":"25","author":"J Nilsson","year":"2005","unstructured":"Nilsson, J., Hansson, G. K. & Shah, P. K. Immunomodulation of atherosclerosis: Implications for vaccine development. Arterioscler. Thromb. Vasc. Biol. 25, 18\u201328. https:\/\/doi.org\/10.1161\/01.ATV.0000149142.42590.a2 (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1176_CR5","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1160\/TH12-10-0768","volume":"109","author":"F Carbone","year":"2013","unstructured":"Carbone, F., Nencioni, A., Mach, F., Vuilleumier, N. & Montecucco, F. Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases. Thromb. Haemost. 109, 854\u2013868. https:\/\/doi.org\/10.1160\/TH12-10-0768 (2013).","journal-title":"Thromb. Haemost."},{"key":"1176_CR6","doi-asserted-by":"publisher","first-page":"11810","DOI":"10.1073\/pnas.92.25.11810","volume":"92","author":"U Sahin","year":"1995","unstructured":"Sahin, U. et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. U. S. A. 92, 11810\u201311813. https:\/\/doi.org\/10.1073\/pnas.92.25.11810 (1995).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1176_CR7","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1073\/pnas.94.5.1914","volume":"94","author":"YT Chen","year":"1997","unstructured":"Chen, Y. T. et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. U. S. A. 94, 1914\u20131918. https:\/\/doi.org\/10.1073\/pnas.94.5.1914 (1997).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1176_CR8","first-page":"3227","volume":"27","author":"T Shiratori","year":"2007","unstructured":"Shiratori, T. et al. Sensitization against anticancer drugs by transfection with UBE2I variant gene into ras-NIH3H3 mouse fibroblasts. Anticancer Res. 27, 3227\u20133233 (2007).","journal-title":"Anticancer Res."},{"key":"1176_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1477-5956-9-31","volume":"9","author":"A Kagaya","year":"2011","unstructured":"Kagaya, A. et al. Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma. Proteome Sci. 9, 31. https:\/\/doi.org\/10.1186\/1477-5956-9-31 (2011).","journal-title":"Proteome Sci."},{"key":"1176_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4172\/1948-5956.1000326","volume":"7","author":"H Shimada","year":"2015","unstructured":"Shimada, H. et al. Elevated serum antibody levels against cyclin L2 in patients with esophageal squamous cell carcinoma. J. Cancer Sci. Ther. 7, 60\u201366. https:\/\/doi.org\/10.4172\/1948-5956.1000326 (2015).","journal-title":"J. Cancer Sci. Ther."},{"key":"1176_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1348-0421.2004.tb03472.x","volume":"48","author":"M Kaneko","year":"2004","unstructured":"Kaneko, M. et al. Serological identification of endothelial antigens predominantly recognized in Kawasaki disease patients by recombinant expression cloning. Microbiol. Immunol. 48, 703\u2013711. https:\/\/doi.org\/10.1111\/j.1348-0421.2004.tb03472.x (2004).","journal-title":"Microbiol. Immunol."},{"key":"1176_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2155-9929.1000219","volume":"6","author":"K Goto","year":"2015","unstructured":"Goto, K. et al. Identification of cerebral infarction-specific antibody markers from autoantibodies detected in patients with systemic lupus erythematosus. J. Mol. Biomark. Diagn. 6, 2. https:\/\/doi.org\/10.4172\/2155-9929.1000219 (2015).","journal-title":"J. Mol. Biomark. Diagn."},{"key":"1176_CR13","doi-asserted-by":"publisher","first-page":"R1133","DOI":"10.1186\/ar1798","volume":"7","author":"Y Lu","year":"2005","unstructured":"Lu, Y., Ye, P., Chen, S. L., Tan, E. M. & Chan, E. K. Identification of kinectin as a novel Beh\u00e7et\u2019s disease autoantigen. Arthritis Res. Ther. 7, R1133\u2013R1139. https:\/\/doi.org\/10.1186\/ar1798 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"1176_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJM197608122950707","volume":"295","author":"R Ross","year":"1976","unstructured":"Ross, R. & Glomset, J. A. The pathogenesis of atherosclerosis (first of two parts). N. Engl. J Med. 295, 369\u2013377. https:\/\/doi.org\/10.1056\/NEJM197608122950707 (1976).","journal-title":"N. Engl. J Med."},{"key":"1176_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross, R. Atherosclerosis\u2014An inflammatory disease. N. Engl. J. Med. 340, 115\u2013126. https:\/\/doi.org\/10.1056\/NEJM199901143400207 (1999).","journal-title":"N. Engl. J. Med."},{"key":"1176_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/01.atv.6.2.131","volume":"6","author":"L Jonasson","year":"1986","unstructured":"Jonasson, L., Holm, J., Skalli, O., Bondjers, G. & Hansson, G. K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6, 131\u2013138. https:\/\/doi.org\/10.1161\/01.atv.6.2.131 (1986).","journal-title":"Arteriosclerosis"},{"key":"1176_CR17","first-page":"169","volume":"135","author":"GK Hansson","year":"1989","unstructured":"Hansson, G. K., Holm, J. & Jonasson, L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135, 169\u2013175 (1989).","journal-title":"Am. J. Pathol."},{"key":"1176_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/0090-1229(90)90155-j","volume":"56","author":"QB Xu","year":"1990","unstructured":"Xu, Q. B., Oberhuber, G., Gruschwitz, M. & Wick, G. Immunology of atherosclerosis: Cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin. Immunol. Immunopathol. 56, 344\u2013359. https:\/\/doi.org\/10.1016\/0090-1229(90)90155-j (1990).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"1176_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12967-015-0393-4","volume":"13","author":"T Machida","year":"2015","unstructured":"Machida, T. et al. Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX). J. Transl. Med. 13, 71. https:\/\/doi.org\/10.1186\/s12967-015-0393-4 (2015).","journal-title":"J. Transl. Med."},{"key":"1176_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.18314\/gjbs.v1i2.27","volume":"1","author":"T Hiwasa","year":"2015","unstructured":"Hiwasa, T. et al. Association of serum antibody levels against TUBB2C with diabetes and cerebral infarction. Integr. Biomed. Sci. 1, 49\u201363. https:\/\/doi.org\/10.18314\/gjbs.v1i2.27 (2015).","journal-title":"Integr. Biomed. Sci."},{"key":"1176_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/1745-7580.1000097","volume":"11","author":"T Hiwasa","year":"2015","unstructured":"Hiwasa, T. et al. Elevated levels of autoantibodies against ATP2B4 and BMP-1 in sera of patients with atherosclerosis-related disease. Immunome Res. 11, 1\u20139. https:\/\/doi.org\/10.4172\/1745-7580.1000097 (2015).","journal-title":"Immunome Res."},{"key":"1176_CR22","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.18632\/oncotarget.23653","volume":"9","author":"Y Yoshida","year":"2018","unstructured":"Yoshida, Y. et al. Elevation of autobody level against PDCD11 in patients with transient ischemic attack. Oncotarget 9, 8836\u20138848. https:\/\/doi.org\/10.18632\/oncotarget.23653 (2018).","journal-title":"Oncotarget"},{"key":"1176_CR23","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.18632\/oncotarget.23789","volume":"9","author":"H Wang","year":"2017","unstructured":"Wang, H. et al. Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction. Oncotarget 9, 5600\u20135613. https:\/\/doi.org\/10.18632\/oncotarget.23789 (2017).","journal-title":"Oncotarget"},{"key":"1176_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2176\/nmc.ra.2018-0022","volume":"58","author":"Y Yoshida","year":"2018","unstructured":"Yoshida, Y. et al. Elevation of autoantibody in patients with ischemic stroke. Neurol. Med. Chir. 58, 303\u2013310. https:\/\/doi.org\/10.2176\/nmc.ra.2018-0022 (2018).","journal-title":"Neurol. Med. Chir."},{"key":"1176_CR25","doi-asserted-by":"publisher","first-page":"e04661","DOI":"10.1016\/j.heliyon.2020.e04661","volume":"6","author":"Y Yoshida","year":"2020","unstructured":"Yoshida, Y. et al. Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases. Heliyon 6, e04661. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04661 (2020).","journal-title":"Heliyon"},{"key":"1176_CR26","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMsb020987","volume":"347","author":"GW Albers","year":"2002","unstructured":"Albers, G. W. et al. Transient ischemic attack\u2014Proposal for a new definition. N. Engl. J. Med. 347, 1713\u20131716. https:\/\/doi.org\/10.1056\/NEJMsb020987 (2002).","journal-title":"N. Engl. J. Med."},{"key":"1176_CR27","first-page":"1001","volume":"1","author":"R Nakamura","year":"2017","unstructured":"Nakamura, R. et al. An anti-deoxyhypusine synthase antibody as a marker of atherosclerosis-related cerebral infarction, myocardial infarction, diabetes mellitus, and chronic kidney disease. SM Atheroscler. J. 1, 1001 (2017).","journal-title":"SM Atheroscler. J."},{"key":"1176_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4172\/1745-7580.1000132","volume":"13","author":"T Hiwasa","year":"2017","unstructured":"Hiwasa, T. et al. Serum SH3BP5-specific antibody level is a biomarker of atherosclerosis. Immunome Res. 13, 132. https:\/\/doi.org\/10.4172\/1745-7580.1000132 (2017).","journal-title":"Immunome Res."},{"key":"1176_CR29","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/ijc.20517","volume":"112","author":"K Nakashima","year":"2004","unstructured":"Nakashima, K. et al. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int. J. Cancer. 112, 1029\u20131035. https:\/\/doi.org\/10.1002\/ijc.20517 (2004).","journal-title":"Int. J. Cancer."},{"key":"1176_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1756-9966-31-85","volume":"31","author":"T Matsutani","year":"2012","unstructured":"Matsutani, T. et al. Autologous antibody to src-homology 3-domain GRP2-like 1 specifically increases in the sera of patients with low-grade gliomas. J. Exp. Clin. Cancer Res. 31, 85. https:\/\/doi.org\/10.1186\/1756-9966-31-85 (2012).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1176_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jneuroim.2015.05.005","volume":"284","author":"M Muto","year":"2015","unstructured":"Muto, M. et al. Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies. J. Neuroimmunol. 284, 30\u201336. https:\/\/doi.org\/10.1016\/j.jneuroim.2015.05.005 (2015).","journal-title":"J. Neuroimmunol."},{"key":"1176_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4172\/2161-0460.1000358","volume":"7","author":"K Sugimoto","year":"2017","unstructured":"Sugimoto, K. et al. Identification of serum anti-GADD34 antibody as a common marker of diabetes mellitus and Parkinson disease. J. Alzheim Dis. Parkins 7, 358. https:\/\/doi.org\/10.4172\/2161-0460.1000358 (2017).","journal-title":"J. Alzheim Dis. Parkins"},{"key":"1176_CR33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4172\/2155-9929.1000361","volume":"8","author":"XM Zhang","year":"2017","unstructured":"Zhang, X. M. et al. Association of serum anti-prolycarboxypeptidase antibody marker with atherosclerotic diseases accompanied by hypertension. J. Mol. Biomark. Diagn. 8, 361. https:\/\/doi.org\/10.4172\/2155-9929.1000361 (2017).","journal-title":"J. Mol. Biomark. Diagn."},{"key":"1176_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12916-021-02001-9","volume":"19","author":"T Hiwasa","year":"2021","unstructured":"Hiwasa, T. et al. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke. BMC Med. 19, 131. https:\/\/doi.org\/10.1186\/s12916-021-02001-9 (2021).","journal-title":"BMC Med."},{"key":"1176_CR35","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","volume":"28","author":"M Cesari","year":"2010","unstructured":"Cesari, M., Pahor, M. & Incalzi, R. A. Plasminogen activator inhibitor-1 (PAI-1): A key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc. Ther. 28, e72\u2013e91. https:\/\/doi.org\/10.1111\/j.1755-5922.2010.00171.x (2010).","journal-title":"Cardiovasc. Ther."},{"key":"1176_CR36","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1055\/s-0038-1646899","volume":"62","author":"C Jern","year":"1989","unstructured":"Jern, C. et al. Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb. Haemost. 62, 767\u2013771 (1989).","journal-title":"Thromb. Haemost."},{"key":"1176_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0049-3848(97)00300-9","volume":"89","author":"Y Takada","year":"1998","unstructured":"Takada, Y., Urano, T., Takahashi, H., Nagai, N. & Takada, A. Effects of electric footshock and water immersion restraint stresses on fibrinolytic parameters in the plasma of rats. Thromb. Res. 89, 107\u2013114. https:\/\/doi.org\/10.1016\/s0049-3848(97)00300-9 (1998).","journal-title":"Thromb. Res."},{"key":"1176_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/00042192-200512020-00006","volume":"12","author":"L Bouchard","year":"2005","unstructured":"Bouchard, L., Mauri\u00e8ge, P., Vohl, M. C., Bouchard, C. & P\u00e9russe, L. Plasminogen-activator inhibitor-1 polymorphisms are associated with obesity and fat distribution in the Quebec Family Study: Evidence of interactions with menopause. Menopause 12, 136\u2013143. https:\/\/doi.org\/10.1097\/00042192-200512020-00006 (2005).","journal-title":"Menopause"},{"key":"1176_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0149-7634(94)90027-2","volume":"18","author":"GB Glavin","year":"1994","unstructured":"Glavin, G. B., Par\u00e9, W. P., Sandbak, T., Bakke, H. K. & Murison, R. Restraint stress in biomedical research: An update. Neurosci. Biobehav. Rev. 18, 223\u2013249. https:\/\/doi.org\/10.1016\/0149-7634(94)90027-2 (1994).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1176_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0049-3848(95)91607-m","volume":"77","author":"CH Ho","year":"1995","unstructured":"Ho, C. H., Chwang, L. C. & Hwang, B. H. The influence of high fat diet on the fibrinolytic activity. Thromb. Res. 77, 201\u2013208. https:\/\/doi.org\/10.1016\/0049-3848(95)91607-m (1995).","journal-title":"Thromb. Res."},{"key":"1176_CR41","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1056\/NEJM200006153422406","volume":"342","author":"HP Kohler","year":"2000","unstructured":"Kohler, H. P. & Grant, P. J. Plasminogen-activator inhibitor type 1 and coronary artery disease. N. Engl. J. Med. 342, 1792\u20131801. https:\/\/doi.org\/10.1056\/NEJM200006153422406 (2000).","journal-title":"N. Engl. J. Med."},{"key":"1176_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1475-2840-10-23","volume":"10","author":"Z Al-Hamodi","year":"2011","unstructured":"Al-Hamodi, Z., Ismail, I. S., Saif-Ali, R., Ahmed, K. A. & Muniandy, S. Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects. Cardiovasc. Diabetol. 10, 23. https:\/\/doi.org\/10.1186\/1475-2840-10-23 (2011).","journal-title":"Cardiovasc. Diabetol."},{"key":"1176_CR43","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.gene.2018.06.040","volume":"673","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. The roles of PAI-1 gene polymorphisms in atherosclerotic diseases: A systematic review and meta-analysis involving 149,908 subjects. Gene 673, 167\u2013173. https:\/\/doi.org\/10.1016\/j.gene.2018.06.040 (2018).","journal-title":"Gene"},{"key":"1176_CR44","doi-asserted-by":"publisher","first-page":"17714","DOI":"10.1038\/srep17714","volume":"6","author":"J Yarmolinsky","year":"2016","unstructured":"Yarmolinsky, J. et al. Plasminogen activator inhibitor-1 and type 2 diabetes: A systematic review and meta-analysis of observational studies. Sci. Rep. 6, 17714. https:\/\/doi.org\/10.1038\/srep17714 (2016).","journal-title":"Sci. Rep."},{"key":"1176_CR45","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1097\/HJH.0000000000002204","volume":"37","author":"A Jacobs","year":"2019","unstructured":"Jacobs, A., Schutte, A. E., Ricci, C. & Pieters, M. Plasminogen activator inhibitor-1 activity and the 4G\/5G polymorphism are prospectively associated with blood pressure and hypertension status. J. Hypertens. 37, 2361\u20132370. https:\/\/doi.org\/10.1097\/HJH.0000000000002204 (2019).","journal-title":"J. Hypertens."},{"key":"1176_CR46","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s40520-015-0504-3","volume":"28","author":"M Gorska-Ciebiada","year":"2016","unstructured":"Gorska-Ciebiada, M., Saryusz-Wolska, M., Borkowska, A., Ciebiada, M. & Loba, J. Plasma levels of thrombomodulin, plasminogen activator inhibitor-1 and fibrinogen in elderly, diabetic patients with depressive symptoms. Aging Clin. Exp. Res. 28, 843\u2013851. https:\/\/doi.org\/10.1007\/s40520-015-0504-3 (2016).","journal-title":"Aging Clin. Exp. Res."},{"key":"1176_CR47","doi-asserted-by":"publisher","first-page":"680","DOI":"10.5551\/jat.11767","volume":"19","author":"LT Tran","year":"2012","unstructured":"Tran, L. T., Park, H. J. & Kim, H. D. Is the carotid intima-media thickness really a good surrogate marker of atherosclerosis?. J. Atheroscler. Thromb. 19, 680\u2013690. https:\/\/doi.org\/10.5551\/jat.11767 (2012).","journal-title":"J. Atheroscler. Thromb."},{"key":"1176_CR48","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1161\/01.atv.20.6.1622","volume":"20","author":"M Zureik","year":"2000","unstructured":"Zureik, M. et al. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: Longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler. Thromb. Vasc. Biol. 20, 1622\u20131629. https:\/\/doi.org\/10.1161\/01.atv.20.6.1622 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1176_CR49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.atherosclerosis.2011.08.007","volume":"220","author":"T Koivistoinen","year":"2012","unstructured":"Koivistoinen, T. et al. Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flow-mediated dilation and carotid artery distensibility: The Cardiovascular Risk in Young Finns Study and the Health 2000 Survey. Atherosclerosis 220, 387\u2013393. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.08.007 (2012).","journal-title":"Atherosclerosis"},{"key":"1176_CR50","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/01.str.28.3.518","volume":"28","author":"T Mannami","year":"1997","unstructured":"Mannami, T., Konishi, M., Baba, S., Nishi, N. & Terao, A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: The Suita study. Stroke 28, 518\u2013525. https:\/\/doi.org\/10.1161\/01.str.28.3.518 (1997).","journal-title":"Stroke"},{"key":"1176_CR51","doi-asserted-by":"publisher","first-page":"6998","DOI":"10.1073\/pnas.89.15.6998","volume":"89","author":"J Schneiderman","year":"1992","unstructured":"Schneiderman, J. et al. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. U. S. A. 89, 6998\u20137002. https:\/\/doi.org\/10.1073\/pnas.89.15.6998 (1992).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1176_CR52","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1161\/01.atv.15.9.1432","volume":"15","author":"PN Raghunath","year":"1995","unstructured":"Raghunath, P. N. et al. Plasminogen activator system in human coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15, 1432\u20131443. https:\/\/doi.org\/10.1161\/01.atv.15.9.1432 (1995).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1176_CR53","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1161\/01.atv.13.7.1090","volume":"13","author":"F Lupu","year":"1993","unstructured":"Lupu, F. et al. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler. Thromb. 13, 1090\u20131100. https:\/\/doi.org\/10.1161\/01.atv.13.7.1090 (1993).","journal-title":"Arterioscler. Thromb."},{"key":"1176_CR54","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1160\/TH08-07-0473","volume":"100","author":"I Diebold","year":"2008","unstructured":"Diebold, I., Kraicun, D., Bonello, S. & G\u00f6rlach, A. The \u2018PAI-1 paradox\u2019 in vascular remodeling. Thromb. Haemost. 100, 984\u2013991 (2008).","journal-title":"Thromb. Haemost."},{"key":"1176_CR55","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1161\/01.res.73.4.671","volume":"73","author":"H Sawa","year":"1993","unstructured":"Sawa, H., Sobel, B. E. & Fujii, S. Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen activator inhibitor type 1 by endothelial injury. Circ. Res. 73, 671\u2013680. https:\/\/doi.org\/10.1161\/01.res.73.4.671 (1993).","journal-title":"Circ. Res."},{"key":"1176_CR56","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1369\/jhc.4A6260.2004","volume":"52","author":"DJ Schneider","year":"2004","unstructured":"Schneider, D. J. et al. Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1). J. Histochem. Cystochem. 52, 1091\u20131099. https:\/\/doi.org\/10.1369\/jhc.4A6260.2004 (2004).","journal-title":"J. Histochem. Cystochem."},{"key":"1176_CR57","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/0140-6736(93)90998-v","volume":"341","author":"PM Ridker","year":"1993","unstructured":"Ridker, P. M., Vaughan, D. E., Stampfer, M. J., Manson, J. E. & Hennekens, C. H. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 341, 1165\u20131168. https:\/\/doi.org\/10.1016\/0140-6736(93)90998-v (1993).","journal-title":"Lancet"},{"key":"1176_CR58","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1161\/01.cir.88.5.2030","volume":"88","author":"JH Jansson","year":"1993","unstructured":"Jansson, J. H., Olofsson, B. O. & Nilsson, T. K. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up. Circulation 88, 2030\u20132034. https:\/\/doi.org\/10.1161\/01.cir.88.5.2030 (1993).","journal-title":"Circulation"},{"key":"1176_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/oxfordjournals.eurheartj.a059862","volume":"12","author":"JH Jansson","year":"1991","unstructured":"Jansson, J. H., Nilsson, T. K. & Olofsson, B. O. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris. Eur. Heart J. 12, 157\u2013161. https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a059862 (1991).","journal-title":"Eur. Heart J."},{"key":"1176_CR60","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1161\/01.str.27.6.1066","volume":"27","author":"A Lindgren","year":"1996","unstructured":"Lindgren, A., Lindoff, C., Norrving, B., Astedt, B. & Johansson, B. B. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke 27, 1066\u20131071. https:\/\/doi.org\/10.1161\/01.str.27.6.1066 (1996).","journal-title":"Stroke"},{"key":"1176_CR61","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1161\/01.atv.20.8.2019","volume":"20","author":"B Wiman","year":"2000","unstructured":"Wiman, B. et al. Plasma levels of tissue plasminogen activator\/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Arterioscler. Thromb. Vasc. Biol. 20, 2019\u20132023. https:\/\/doi.org\/10.1161\/01.atv.20.8.2019 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1176_CR62","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1182\/blood.V78.2.401.401","volume":"78","author":"J Keijer","year":"1991","unstructured":"Keijer, J. et al. The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: Localization of interaction sites and physiologic relevance. Blood 78, 401\u2013409 (1991).","journal-title":"Blood"},{"key":"1176_CR63","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1182\/blood-2013-07-517060","volume":"123","author":"FA Scheer","year":"2014","unstructured":"Scheer, F. A. & Shea, S. A. Human circadian system causes a morning peak in prothrombotic plasminogen activator inhibitor-1 (PAI-1) independent of the sleep\/wake cycle. Blood 123, 590\u2013593. https:\/\/doi.org\/10.1182\/blood-2013-07-517060 (2014).","journal-title":"Blood"},{"key":"1176_CR64","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1111\/j.1538-7836.2005.01420.x","volume":"3","author":"DE Vaughan","year":"2005","unstructured":"Vaughan, D. E. PAI-1 and atherothrombosis. J. Thromb. Haemost. 3, 1879\u20131883. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01420.x (2005).","journal-title":"J. Thromb. Haemost."},{"key":"1176_CR65","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1227\/00006123-199407000-00004","volume":"35","author":"Y Fujii","year":"1994","unstructured":"Fujii, Y. et al. Serial changes in hemostasis after intracranial surgery. Neurosurgery 35, 26\u201333. https:\/\/doi.org\/10.1227\/00006123-199407000-00004 (1994).","journal-title":"Neurosurgery"},{"key":"1176_CR66","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1213\/00000539-199303000-00009","volume":"76","author":"G Freyburger","year":"1993","unstructured":"Freyburger, G., Janvier, G., Dief, S. & Boisseau, M. R. Fibrinolytic and hemorheologic alterations during and after elective aortic graft surgery: Implications for postoperative management. Anesth. Analg. 76, 504\u2013512. https:\/\/doi.org\/10.1213\/00000539-199303000-00009 (1993).","journal-title":"Anesth. Analg."},{"key":"1176_CR67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/bios8030067","volume":"8","author":"J Qiu","year":"2018","unstructured":"Qiu, J., Keyser, B., Lin, Z. T. & Wu, T. Autoantibodies as potential biomarkers in breast cancer. Biosensors 8, 67. https:\/\/doi.org\/10.3390\/bios8030067 (2018).","journal-title":"Biosensors"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01176-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01176-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01176-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T17:12:17Z","timestamp":1670087537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01176-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1176"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-01176-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"14 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21772"}}